Related Experiment Video
Updated: Mar 3, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Consumer perceptions of and willingness-to-pay for point-of-care testing services in the community pharmacy
Kenneth C Hohmeier1, Benjamin Loomis2, Justin Gatwood1
1Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Nashville, TN, USA.
Background:
Point-of-care testing (POCT) is a specialty of laboratory medicine that occurs at the bedside or near the patient when receiving health services. Despite its clinical utility, POCT implementation in the community pharmacy setting is slow due to uncertainty about the market for this novel service and remuneration for services rendered.
Objective:
To identify 1) demographics and 2) willingness-to-pay preferences of the market niche of consumers who prefer to receive POCT services in the community pharmacy.
Methods:
A sample of 188 participants matched to the U.S. population were surveyed in February of 2016 utilizing a self-explicated conjoint analysis survey model.
Results:
Age groups differed between the community pharmacy consumer niche and the entire sample. The largest age group of the pharmacy niche consumer group were between 20 and 34 years old. Of those who preferred the community pharmacy setting to receive POCT services, 75% indicated they would be willing to pay $50 or more compared to 79% of the entire sample who preferred to pay $50 or less.
Conclusions:
There exists a latent and niche group of consumers interested in community pharmacy provided POCT services. This market niche is younger, and in general willing-to-pay more than the general population for these tests.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Drug Concentrations: Measurements
Plasma...
Errors occurring during blood pressure monitoring
Several factors...
Pneumonia III: Complications and Assessment
Analysis of Population Pharmacokinetic Data

